Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Nicolas Jose Rodriguez

219 posts
Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

PharmaTher Presents Positive Data On Ketamine For Treatment Of Dyskinesia In Parkinson’s Disease

By Nicolas Jose Rodriguez
September 17, 6:09 PM
PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM), a leader in specialty ketamine pharmaceuticals, announced Friday that the Phase 1/2 clinical study of ketamine in the treatment of levodopa-induced dyskinesia in Parkinson’s disease was presented at the MDS

CSE:PHRM

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Cannabis
  • Downgrades
  • Earnings
  • Economics
  • Guidance
  • Management
  • Markets
  • News
  • Price Target
  • Retail Sales

Is Fire & Flower Joining ‘The Discount Parade’? New Strategy Boosts Retail Cannabis Sales

By Nicolas Jose Rodriguez
September 15, 4:40 PM
The Analyst 

FFLWD

Read More
3 minute read
  • Analyst Color
  • Analyst Ratings
  • Cannabis
  • Markets
  • Penny Stocks

Want Exposure To The Canadian Recreational Cannabis Market? These Are The 3 Best Picks, According To A Cantor Analyst

By Nicolas Jose Rodriguez
September 14, 7:31 PM
In a recent analyst note, Pablo Zuanic from Cantor Fitzgerald offered an update on the performance of Canada’s cannabis Licensed Producers in the August quarter, based on data obtained by the market scanner Hifyre.

HEXO

Read More
3 minute read
  • Cannabis
  • Events
  • Exclusives
  • Market-Moving Exclusives
  • Markets
  • News
  • Penny Stocks

‘Write Checks To Women’: GTII’s Wendy Berger At Benzinga Cannabis Conference On How To ‘Elevate Women’ In The Industry

By Nicolas Jose Rodriguez
September 13, 12:25 PM
Wendy Berger has been a board member of Green Thumb Industries Inc. (OTC: GTII) since 2015 and is one of the pioneers among women leaders in the cannabis industry.

GTBIF

Read More
4 minute read
  • Analyst Color
  • Analyst Ratings
  • Cannabis
  • Large Cap
  • M&A
  • Management
  • Markets
  • News
  • Penny Stocks
  • Retail Sales
  • Small Cap

Update On Cannabis M&A: Aurora, TerrAscend, SNDL, Curaleaf, And… A Costly Preferred Stock Raise?

By Nicolas Jose Rodriguez
September 1, 8:35 PM
On Thursday, analyst Pablo Zuanic from Cantor Fitzgerald offered an industry update on four recent M&A deals and Glasshouse Series B Preferred stock issuance.

ACB

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Markets
  • News
  • Penny Stocks
  • Psychedelics
  • Success Stories

Cybin Announces First Dosing In Human Trial With Proprietary Psychedelic Drug For Depression

By Nicolas Jose Rodriguez
August 30, 7:45 PM
Cybin Inc.

CYBN

Read More
10 minute read
  • Cannabis
  • Entrepreneurship
  • Exclusives
  • General
  • Penny Stocks
  • Travel

Jimi Devine’s Dream Job: How This Guy Became A Hashish Judge And Cannabis Reviewer

By Nicolas Jose Rodriguez
August 26, 2:32 PM
Via El Planteo - Original publication: September 8, 2021.

LFLY

Read More
2 minute read
  • Cannabis
  • Markets
  • News

Marketing Cannabis On Instagram And TikTok In 2022: Tips And Tricks To Make A Splash

By Nicolas Jose Rodriguez
August 26, 12:51 PM
Joey Brabo and Mitch Pfeifer are co-owners of Respect My Region (RMR,) a music, cannabis and media company that exploded onto the cannabis scene in 2018 with a viral post on Christmas Eve when a video featuring the California-based cannabis lawyers, the "Pot Brothers at Law," went viral on the company&r

FB

Read More
2 minute read
  • Cannabis
  • Markets

Amazon Rejected Your Job Application Due To Weed Use? Worry Not, You May Be Eligible Now

By Nicolas Jose Rodriguez
August 25, 4:55 PM
Original publication: September 21, 2021

AMZN

Read More
8 minute read
  • Cannabis
  • Events
  • Exclusives
  • Markets
  • News

What Are The Most Innovative Cannabis Brands Out There? Benzinga’s Cannabis Capital Conference Aims To Find Out

By Nicolas Jose Rodriguez
August 23, 10:47 AM
Strictly speaking, innovating in cannabis represents the improvement of a function of production or the introduction of a new material that creates value for markets. Cannabis innovation can be seen along the cannabis supply chain.

CGC

Posts navigation

Previous 1 … 3 4 5 … 22 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service